New research suggests that patients who discontinue popular slimming jabs like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise programs.
Published data in a prominent medical journal demonstrates that while obese people frequently drop a large proportion of their body weight while undergoing treatment, the weight returns at an average rate of nearly a kilo each month upon discontinuation.
"People buying these drugs should be aware of the risk of fast rebound weight gain when the therapy is stopped," stated expert Dr. Susan Jebb.
This pace of regain implies a reversion to original weight within about a year and a half.
Analyzing Therapies
The analysis, which examined dozens of trials involving thousands of participants, contrasted the effects of GLP-1 agonists with older methods.
Researchers emphasize that people who shed pounds through diet and exercise generally have a less rapid creep back—perhaps 0.1 kg a month—post-intervention.
Explaining the Quick Regain
Nutrition scientists propose the mode of action of the injections explains the heightened weight return.
GLP-1 drugs imitate a body's own chemical called GLP-1, which moderates feelings of fullness.
"Long-term administration of GLP-1 concentrations far above than normal could lead to the system to produce less of its endogenous hormone, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this GLP-1 'fix' means appetite is no longer kept in check, making binge eating far more likely."
A Lifelong Disease?
Health authorities recommend the jabs for people with obesity-related health risks, alongside recommended lifestyle changes.
Many experts say that, given the high risk of weight regain, the treatment is often long-term.
This view is reinforced by drug manufacturers, who say that the findings "underscore the chronic nature of excess weight," comparing it to managing conditions like high blood pressure.
User Testimonies
Users who have discontinued the jabs explain a powerful return of hunger.
"It was like something flipping and you're instantly starving," said an individual.
This challenge is exacerbated if users have not established sustainable lifestyle or habit modifications during treatment.
Widespread Interest
Survey data indicate that millions of people in the UK have tried these injections in the past year, with desire being substantial.
- Use is higher among females than males.
- The middle-aged demographic shows the highest usage rates.
- Many obtain the medications through private healthcare rather than the NHS.
Ultimately, experts stress that while GLP-1 drugs are powerful tools for weight loss, they are not a standalone fix and long-term success likely depends on combined lifestyle management.
